Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma

被引：3
|
作者：
Huang, Shang-Xiao [1 ]
Luo, Peng-Hui [1 ]
Wang, Han-Lei [1 ]
Mo, Dun-Chang [1 ]
Huang, Jian-Feng [1 ]
机构：
[1] Nanning Second Peoples Hosp, Radiotherapy Dept, Nanning, Guangxi, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 14期
关键词：
D O I：
10.1200/JCO.22.02665
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2667 / 2668
页数：2
相关论文
共 50 条
  • [1] NICE guidance on daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma
    Elsada, Ahmed
    Adler, Amanda I.
    [J]. LANCET ONCOLOGY, 2019, 20 (05): : 619 - 620
  • [2] Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
    Palumbo, Antonio
    Chanan-Khan, Asher
    Weisel, Katja
    Nooka, Ajay K.
    Masszi, Tamas
    Beksac, Meral
    Spicka, Ivan
    Hungria, Vania
    Munder, Markus
    Mateos, Maria V.
    Mark, Tomer M.
    Qi, Ming
    Schecter, Jordan
    Amin, Himal
    Qin, Xiang
    Deraedt, William
    Ahmadi, Tahamtan
    Spencer, Andrew
    Sonneveld, Pieter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08): : 754 - 766
  • [3] Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Quach, Hang
    Ho, P. Joy
    Beksac, Meral
    Hulin, Cyrille
    Antonioli, Elisabetta
    Leleu, Xavier
    Mangiacavalli, Silvia
    Perrot, Aurore
    Cavo, Michele
    Belotti, Angelo
    Broijl, Annemiek
    Gay, Francesca
    Mina, Roberto
    Nijhof, Inger S.
    van de Donk, Niels W. C. J.
    Katodritou, Eirini
    Schjesvold, Fredrik
    Sureda Balari, Anna
    Rosinol, Laura
    Delforge, Michel
    Roeloffzen, Wilfried
    Silzle, Tobias
    Vangsted, Annette
    Einsele, Hermann
    Spencer, Andrew
    Hajek, Roman
    Jurczyszyn, Artur
    Lonergan, Sarah
    Ahmadi, Tahamtan
    Liu, Yanfang
    Wang, Jianping
    Vieyra, Diego
    van Brummelen, Emilie M. J.
    Vanquickelberghe, Veronique
    Sitthi-Amorn, Anna
    de Boer, Carla J.
    Carson, Robin
    Rodriguez-Otero, Paula
    Blade, Joan
    Moreau, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 301 - 313
  • [4] Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR
    Mateos, Maria-Victoria
    Sonneveld, Pieter
    Hungria, Vania
    Nooka, Ajay K.
    Estell, Jane A.
    Barreto, Wolney
    Corradini, Paolo
    Min, Chang-Ki
    Medvedova, Eva
    Weisel, Katja
    Chiu, Christopher
    Schecter, Jordan M.
    Amin, Himal
    Qin, Xiang
    Ukropec, Jon
    Kobos, Rachel
    Spencer, Andrew
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (08): : 509 - 518
  • [5] Selinexor–Bortezomib–Dexamethasone: A Review in Previously Treated Multiple Myeloma
    Yahiya Y. Syed
    [J]. Targeted Oncology, 2023, 18 : 303 - 310
  • [6] Selinexor-Bortezomib-Dexamethasone: A Review in Previously Treated Multiple Myeloma
    Syed, Yahiya Y.
    [J]. TARGETED ONCOLOGY, 2023, 18 (02) : 303 - 310
  • [7] Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma
    Rahbari, Kian J.
    Nosrati, Jason D.
    Spektor, Tanya M.
    Berenson, James R.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (09): : E339 - E343
  • [8] Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
    Richard, Shambavi
    Chari, Ajai
    Delimpasi, Sosana
    Simonova, Maryana
    Spicka, Ivan
    Pour, Ludek
    Kriachok, Iryna
    Dimopoulos, Meletios A.
    Pylypenko, Halyna
    Auner, Holger W.
    Leleu, Xavier
    Usenko, Ganna
    Hajek, Roman
    Benjamin, Reuben
    Dolai, Tuphan Kanti
    Sinha, Dinesh Kumar
    Venner, Christopher P.
    Garg, Mamta
    Stevens, Don Ambrose
    Quach, Hang
    Jagannath, Sundar
    Moreau, Phillipe
    Levy, Moshe
    Badros, Ashraf
    Anderson, Larry D., Jr.
    Bahlis, Nizar J.
    Facon, Thierry
    Mateos, Maria Victoria
    Cavo, Michele
    Chang, Hua
    Landesman, Yosef
    Chai, Yi
    Arazy, Melina
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Grosicki, Sebastian
    Richardson, Paul G.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1120 - 1130
  • [9] Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone
    Ivan Krečak
    Ivana Ruščić
    Josipa Jović Zlatović
    Marijana Šupe
    Marija Valovičić Krečak
    Velka Gverić-Krečak
    [J]. Annals of Hematology, 2021, 100 : 1623 - 1624
  • [10] Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone
    Krecak, Ivan
    Ruscic, Ivana
    Zlatovic, Josipa Jovic
    Supe, Marijana
    Krecak, Marija Valovicic
    Gveric-Krecak, Velka
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1623 - 1624
12345